KALEIDO & BIOASTER: a successful completion

Kaleido Biosciences and BIOASTER are glad to announce the successful completion of a collaborative project that provided new insights into ways Kaleido’s Microbiome Metabolic Therapies (MMT™) modulate the integrity and function of...

New collaboration with PiLeJe Laboratoire

PiLeJe Laboratoire to collaborate with BIOASTER to investigate the health potential of a probiotic selection Pileje Laboratoire, a French company leader in probiotic-based dietary supplements in Europe and specialized in...

Antimicrobials Program Highlights 2020

Hopefully, we will have a chance to share updates face to face, in the meantime we are happy to highlight some of the 2020 Antimicrobials Program achievements. If this should...

LUMI-Seq®: New video on line!

LUMI-Seq®: New video on line! Check out the new Designed BY BIOASTER video about LUMI-Seq® technology: A novel targeted sequencing  technology for generating long reads from Illumina sequencers.  

BIOASTER 2021

2020, with the sudden and severe emergence of SARS-CoV-2, has shown that teaming-up and collaborating is our best option in coming together against a pandemic. More than ever, BIOASTER’s purpose...

Open Call: Apply for TRANSVAC2 Vaccine Development Services

Open Call: Apply for TRANSVAC2 Vaccine Development Services Developing a vaccine is a time-consuming and complex process, requiring a combination of specialized skills and technical capacities not readily available at...
Post archive